Leflunomide and peripheral neuropathy: a potential interaction between uracil/tegafur and leflunomide.
Kopp
H-G
HG
Moerike
K
K
Kanz
L
L
Hartmann
J T
JT
D000284:Administration, Oral; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy; D015897:Comorbidity; D018450:Disease Progression; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D000077339:Leflunomide; D008297:Male; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D011115:Polyneuropathies / Q000209:etiology; D012004:Rectal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D005641:Tegafur / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors; D014498:Uracil / Q000009:adverse effects* / Q000627:therapeutic use
D004338:Drug Combinations; D007555:Isoxazoles; D005641:Tegafur; D014498:Uracil; D000077339:Leflunomide; D005472:Fluorouracil